Paper42715331
Early detection of invasive lung cancer and multiorgan metastasis by a collagen-targeted protein MRI contrast agent.
Li D and 26 others. Sci Adv, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Early detection of invasive lung cancer and multiorgan metastasis by a collagen-targeted protein MRI contrast agent. Papers, record 42715331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42715331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Early detection of invasive lung cancer and multiorgan metastasis by a collagen-targeted protein MRI contrast agent.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Contrast Media | Major topic |
| Lung Neoplasms | Major topic |
| Magnetic Resonance Imaging | Major topic |
| Collagen | Major topic |
| Early Detection of Cancer | Major topic |
| Humans | |
| Animals | |
| Neoplasm Metastasis | |
| Mice | |
| Cell Line, Tumor | |
| Female | |
| Neoplasm Invasiveness |
Source PubMed
Grants12
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 CA194027 | NCI NIH HHS | United States | R01CA194027 | PubMed | NIH RePORTER |
| S10 OD027045 | NIH HHS | United States | S10OD027045 | PubMed | NIH RePORTER |
| R42 AA025863 | NIAAA NIH HHS | United States | R42AA025863 | PubMed | NIH RePORTER |
| R01 CA203928 | NCI NIH HHS | United States | R01CA203928 | PubMed | NIH RePORTER |
| UT2 AA028659 | NIAAA NIH HHS | United States | UT2AA028659 | PubMed | NIH RePORTER |
| R01 EB007268 | NIBIB NIH HHS | United States | R01EB007268 | PubMed | NIH RePORTER |
| R33 CA235319 | NCI NIH HHS | United States | R33CA235319 | PubMed | NIH RePORTER |
| R44 CA268403 | NCI NIH HHS | United States | R44CA268403 | PubMed | NIH RePORTER |
| R01 DK126080 | NIDDK NIH HHS | United States | R01DK126080 | PubMed | NIH RePORTER |
| P30 CA138292 | NCI NIH HHS | United States | P30CA138292 | PubMed | NIH RePORTER |
| R42 CA183376 | NCI NIH HHS | United States | R42CA183376 | PubMed | NIH RePORTER |
| P01 CA257906 | NCI NIH HHS | United States | P01CA257906 | PubMed | NIH RePORTER |
References64
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34385702 | Toward personalized treatment approaches for non-small-cell lung cancer. | Nat Med | 2021 | https://conductscience.org/library/papers/34385702 | PubMed |
| 2 | 28289710 | Targeting adhesion signaling in KRAS, LKB1 mutant lung adenocarcinoma. | JCI Insight | 2017 | https://conductscience.org/library/papers/28289710 | PubMed |
| 3 | 33293343 | Leflunomide Suppresses the Growth of LKB1-Inactivated Tumors in the Immune-Competent Host and Attenuates Distant Cancer Metastasis. | Mol Cancer Ther | 2021 | https://conductscience.org/library/papers/33293343 | PubMed |
| 4 | 38180819 | Protein MRI Contrast Agents as an Effective Approach for Precision Molecular Imaging. | Invest Radiol | 2024 | https://conductscience.org/library/papers/38180819 | PubMed |
| 5 | 22695952 | MRI of the lung (1/3): methods. | Insights Imaging | 2012 | https://conductscience.org/library/papers/22695952 | PubMed |
| 6 | 23927643 | Molecular magnetic resonance imaging of pulmonary fibrosis in mice. | Am J Respir Cell Mol Biol | 2013 | https://conductscience.org/library/papers/23927643 | PubMed |
| 7 | 32126587 | Molecular imaging of extracellular matrix proteins with targeted probes using magnetic resonance imaging. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2020 | https://conductscience.org/library/papers/32126587 | PubMed |
| 8 | 30973459 | Physicochemical and Pharmacokinetic Profiles of Gadopiclenol: A New Macrocyclic Gadolinium Chelate With High T1 Relaxivity. | Invest Radiol | 2019 | https://conductscience.org/library/papers/30973459 | PubMed |
| 9 | 14729505 | Recent advances in imaging the lungs of intact small animals. | Am J Respir Cell Mol Biol | 2004 | https://conductscience.org/library/papers/14729505 | PubMed |
| 10 | 18815398 | Lung cancer. | N Engl J Med | 2008 | https://conductscience.org/library/papers/18815398 | PubMed |
| 11 | 36793094 | Detection of solid and subsolid pulmonary nodules with lung MRI: performance of UTE, T1 gradient-echo, and single-shot T2 fast spin echo. | Cancer Imaging | 2023 | https://conductscience.org/library/papers/36793094 | PubMed |
| 12 | 21413080 | Diffusion-weighted hyperpolarized 129Xe MRI in healthy volunteers and subjects with chronic obstructive pulmonary disease. | Magn Reson Med | 2011 | https://conductscience.org/library/papers/21413080 | PubMed |
| 13 | 15938616 | The effects of Ca2+ binding on the dynamic properties of a designed Ca2+-binding protein. | Biochemistry | 2005 | https://conductscience.org/library/papers/15938616 | PubMed |
| 14 | 34261797 | Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade. | Sci Transl Med | 2021 | https://conductscience.org/library/papers/34261797 | PubMed |
| 15 | 32611647 | Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRI. | Clin Cancer Res | 2020 | https://conductscience.org/library/papers/32611647 | PubMed |
| 16 | 19053180 | A peptide targeted contrast agent specific to fibrin-fibronectin complexes for cancer molecular imaging with MRI. | Bioconjug Chem | 2008 | https://conductscience.org/library/papers/19053180 | PubMed |
| 17 | 37388961 | Early Detection and Staging of Lung Fibrosis Enabled by Collagen-Targeted MRI Protein Contrast Agent. | Chem Biomed Imaging | 2023 | https://conductscience.org/library/papers/37388961 | PubMed |
| 18 | 24378917 | Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. | Ann Intern Med | 2014 | https://conductscience.org/library/papers/24378917 | PubMed |
| 19 | 11261657 | Molecular dynamics simulations of MRI-relevant GdIII chelates: direct access to outer-sphere relaxivity. | Chemistry | 2001 | https://conductscience.org/library/papers/11261657 | PubMed |
| 20 | 18344005 | Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review. | Biometals | 2008 | https://conductscience.org/library/papers/18344005 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42539110 | Unmasking Early Hepatorenal Fibrosis in Polycystic Kidney Disease Using Noninvasive Precision Molecular MRI of Collagen. | bioRxiv | 2026 | https://conductscience.org/library/papers/42539110 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| STK11 | 6794 | PubTator's text mining | https://conductscience.org/library/genes/6794 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42715331
GET https://conductscience.org/api/papers/v1/42715331/authors?page=2